Skip to content
Screener

Seres Therapeutics MCRB Q1 2025 earnings

Reported May 7, 2025 · Before market open

EPS-$2.24Miss by $1.57
Revenue estimate$10.0M
EPS estimate-$0.67

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$1.01

FAQ

When did Seres Therapeutics report Q1 2025 earnings?
Seres Therapeutics (MCRB) reported Q1 2025 earnings on May 7, 2025 before market open.
What were Seres Therapeutics's Q1 2025 revenue and EPS?
Seres Therapeutics reported eps of $-2.24 for Q1 2025.
Did Seres Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.67 by $1.57.
How did Seres Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 58.5% from $-5.40.
Where can I find Seres Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-114430) and the 10-Q periodic report (0000950170-25-065173) directly on SEC EDGAR. The filing index links above go to sec.gov.